|
1.
|
M HallekPL BergsagelKC AndersonMultiple
myeloma: increasing evidence for a multistep transformation
processBlood9132119989414264
|
|
2.
|
X FengJ YanY WangJR ZierathM
NordenskjöldJI HenterThe proteasome inhibitor bortezomib disrupts
tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
expression and natural killer (NK) cell killing of TRAIL
receptor-positive multiple myeloma cellsMol
Immunol4723882396201010.1016/j.molimm.2010.05.003
|
|
3.
|
LE PerezN ParquetM MeadsC AnasettiW
DaltonBortezomib restores stroma-mediated APO2L/TRAIL apoptosis
resistance in multiple myelomaEur J
Haematol84212222201010.1111/j.1600-0609.2009.01381.x19922463
|
|
4.
|
T IguchiT Yachide-NoguchiY HashimotoS
NakazatoM SagawaY IkedaM KisakiNovel tubulin-polymerization
inhibitor derived from thalidomide directly induces apoptosis in
human multiple myeloma cells: possible anti-myeloma mechanism of
thalidomideInt J Mol Med211631682008
|
|
5.
|
JA ZonderJ CrowleyMA HusseinV BolejackDF
Moore SrBF WhittenbergerLenalidomide and high-dose dexamethasone
compared with dexamethasone as initial therapy for multiple
myeloma: a randomized Southwest Oncology Group trial
(S0232)Blood11658385841201010.1182/blood-2010-08-30348720876454
|
|
6.
|
M OffidaniP LeoniL CorvattaC PolloniS
GentiliAM LiberatiOutcome and toxicity in the modern era of new
drugs for multiple myeloma: a reappraisal for comparison with
future investigational trialsClin Lymphoma Myeloma
Leuk10353360201010.3816/CLML.2010.n.06821030348
|
|
7.
|
D DingliSV RajkumarHow best to use new
therapies in multiple myelomaBlood
Rev2491100201010.1016/j.blre.2010.03.00120359801
|
|
8.
|
M PetterssonH Jernberg-WiklundLG LarssonC
SundströmI GivolY TsujimotoK NilssonExpression of the bcl-2 gene in
human multiple myeloma cell lines and normal plasma
cellsBlood7949550219921730093
|
|
9.
|
SD PeetersS HovengaS RosatiE
VellengaBcl-xl expression in multiple myelomaMed
Oncol22183190200510.1385/MO:22:2:18315965282
|
|
10.
|
T CaravitaA SiniscalchiA TendasL CupelliM
AlesA PerrottiSafety and efficacy of a combination therapy with
Revlimid, Adriamycin and dexamethasone (RAD) in relapsed/refractory
multiple myeloma (MM): a single-centre experienceAnn
Hematol90115116201110.1007/s00277-010-0967-4
|
|
11.
|
S LucchiD CalebiroT de FilippisES GrassiMO
BorghiL Persani8-Chloro-cyclic AMP and protein kinase A I-selective
cyclic AMP analogs inhibit cancer cell growth through different
mechanismsPLoS
One6e20785201110.1371/journal.pone.002078521695205
|
|
12.
|
N DumazR MaraisIntegrating signals between
cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the
anniversary prize of the Gesellschaft für Biochemie und
Molekularbiologie Lecture delivered on 5 July 2003 at the Special
FEBS Meeting in BrusselsFEBS J27234913504200516008550
|
|
13.
|
YS Cho-ChungRole of cyclic AMP receptor
proteins in growth, differentiation, and suppression of malignancy:
new approaches to therapyCancer Res507093710019902224844
|
|
14.
|
DJ PropperMP SaundersAJ SalisburyL LongKJ
O’ByrneJP BraybrookePhase I study of the novel cyclic AMP (cAMP)
analogue 8-chloro-cAMP in patients with cancer: toxicity, hormonal,
and immunological effectsClin Cancer Res516821689199910430069
|
|
15.
|
JH HanYH AhnKY ChoiSH HongInvolvement of
AMP-activated protein kinase and p38 mitogen-activated protein
kinase in 8-Cl-cAMP-induced growth inhibitionJ Cell
Physiol218104112200910.1002/jcp.2157318756496
|
|
16.
|
V BajicZ StanimirovicJ StevanovicB
Spremo-PotparevicL ZivkovicZ MilicevicCytogenetic effects of
8-Cl-cAMP on human and animal chromosomesJ
BUON147177200919373950
|
|
17.
|
V VucićA NićiforovićM AdzićMB RadojcićS
RuzdijićThe combination of gamma ionizing radiation and 8-Cl-cAMP
induces synergistic cell growth inhibition and induction of
apoptosis in human prostate cancer cellsInvest New
Drugs26309317200818060599
|
|
18.
|
M PesicK DrabekC EslerS RuzdijicV
PejanovicZ PietrzkowskiInhibition of cell growth and proliferation
in human glioma cells and normal human astrocytes induced by
8-Cl-cAMP and tiazofurinNucleosides Nucleotides Nucleic
Acids19963975200010.1080/1525777000803303610893715
|
|
19.
|
Y LiX QuJ QuY ZhangJ LiuY TengArsenic
trioxide induces apoptosis and G2/M phase arrest by inducing Cbl to
inhibit PI3K/Akt signaling and thereby regulate p53
activationCancer
Lett284208215200910.1016/j.canlet.2009.04.03519457607
|
|
20.
|
DT VisticaP SkehanD ScudieroA MonksA
PittmanMR BoydTetrazolium-based assays for cellular viability: a
critical examination of selected parameters affecting formazan
productionCancer Res512515252019912021931
|
|
21.
|
YH AhnJM JungSH Hong8-Chloro-cyclic
AMP-induced growth inhibition and apoptosis is mediated by p38
mitogen-activated protein kinase activation in HL60 cellsCancer
Res6548964901200510.1158/0008-5472.CAN-04-312215930311
|
|
22.
|
TW RallEW SutherlandFormation of a cyclic
adenine ribonucleotide by tissue particlesJ Biol
Chem23210651076195813549487
|
|
23.
|
RW ButcherEW SutherlandAdenosine
3′,5′-phosphate in biological materials. I. Purification and
properties of cyclic 3′,5′-nucleotide phosphodiesterase and use of
this enzyme to characterize adenosine 3′,5′-phosphate in human
urineJ Biol Chem237124412501962
|
|
24.
|
GA RobisonRW ButcherI OyeHE MorganEW
SutherlandThe effect of epinephrine on adenosine 3′,5′-phosphate
levels in the isolated perfused rat heartMol
Pharmacol11681771965
|
|
25.
|
CW AbellTM MonahanThe role of adenosine
3′,5′-cyclic monophosphate in the regulation of mammalian cell
divisionJ Cell Biol595495581973
|
|
26.
|
IH PastanGS JohnsonWB AndersonRole of
cyclic nucleotides in growth controlAnnu Rev
Biochem44491522197510.1146/annurev.bi.44.070175.002423166606
|
|
27.
|
DL FriedmanRole of cyclic nucleotides in
cell growth and differentiationPhysiol Rev566527081976185633
|
|
28.
|
DJ FranksJP MacManusJF WhitfieldThe effect
of prostaglandins on cyclic AMP production and cell proliferation
in thymic lymphocytesBiochem Biophys Res
Commun4411771183197110.1016/S0006-291X(71)80210-34334273
|
|
29.
|
JP MacManusJF WhitfieldT
YoudaleStimulation by epinephrine of adenyl cyclase activity,
cyclic AMP formation, DNA synthesis and cell proliferation in
populations of rat thymic lymphocytesJ Cell
Physiol77103116197110.1002/jcp.10407701124322941
|
|
30.
|
P RalphR HymanR EpsteinI NakoinzM
CohnIndependence of theta and TL surface antigens and killing by
thymidine, cortisol, phytohemagglutinin, and cyclic AMP in a murine
lymphomaBiochem Biophys Res
Commun5510851091197310.1016/S0006-291X(73)80006-34358928
|
|
31.
|
P CoffinoHR BourneGM TomkinsMechanism of
lymphoma cell death induced by cyclic AMPAm J
Pathol811992041975170834
|
|
32.
|
K PonzettiM KingA GatesMS AnwerCR
WebsterCyclic AMP-guanine exchange factor activation inhibits
JNK-dependent lipopolysaccharide-induced apoptosis in rat
hepatocytesHepat Med20101112010
|
|
33.
|
D MoujalledR WestonH AndertonR NinnisP
GoelA ColeyCyclic-AMP-dependent protein kinase A regulates
apoptosis by stabilizing the BH3-only protein BimEMBO
Rep127783201110.1038/embor.2010.19021151042
|
|
34.
|
G TortoraF CiardielloS PepeP TagliaferriA
RuggieroC BiancoPhase I clinical study with 8-chloro-cAMP and
evaluation of immunological effects in cancer patientsClin Cancer
Res137738419959815994
|
|
35.
|
S OginoT KawasakiA OgawaGJ KirknerM LodaCS
FuchsCytoplasmic localization of p27 (cyclin-dependent kinase
inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with
nuclear p27 loss, microsatellite instability, and CpG island
methylator phenotypeHum
Pathol38585592200710.1016/j.humpath.2006.09.014
|
|
36.
|
S IgrejaHS ChahalSA AkkerM GueorguievV
PopovicS DamjanovicAssessment of p27 (cyclin-dependent kinase
inhibitor 1B) and aryl hydrocarbon receptor-interacting protein
(AIP) genes in multiple endocrine neoplasia (MEN1) syndrome
patients without any detectable MEN1 gene mutationsClin Endocrinol
(Oxford)70259264200910.1111/j.1365-2265.2008.03379.x
|
|
37.
|
B WangF NiL LiZ WeiX ZhuJ WangAnalysis of
cyclin-dependent kinase inhibitor 1B mutation in Han Chinese women
with premature ovarian failureReprod Biomed
Online21212214201010.1016/j.rbmo.2010.04.02520615757
|
|
38.
|
Q TongW ZhangS JinS LiZ ChenThe
relationship between p27(kip1) expression and the change of
radiosensitivity of esophageal carcinoma cellsScand J
Gastroenterol46173176201110.3109/00365521.2010.52272120923380
|
|
39.
|
MJ HuangYC ChengCR LiuS LinHE LiuA
small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle
arrest, apoptosis, and myeloid differentiation of human acute
myeloid leukemiaExp
Hematol3414801489200610.1016/j.exphem.2006.06.01917046567
|
|
40.
|
KC JeongKO AhnCH YangSmall-molecule
inhibitors of c-Myc transcriptional factor suppress proliferation
and induce apoptosis of promyelocytic leukemia cell via cell cycle
arrestMol Biosyst615031509201010.1039/c002534h20485733
|
|
41.
|
K OnoJ HanThe p38 signal transduction
pathway: activation and functionCell
Signal12113200010.1016/S0898-6568(99)00071-6
|
|
42.
|
T WadaJM PenningerMitogen-activated
protein kinases in apoptosis
regulationOncogene2328382849200410.1038/sj.onc.120755615077147
|
